Homogeneously staining regions in 223 breast carcinomas: cytogenetic and clinicopathological correlations.

por Bernardino, J., Gerbault-Seureau, M., Zafrani, B., Dericke, Y., Boudou, E., Magdelenat, H., Dutrillaux, B.
Publicado 1998

Are ipsilateral breast tumour invasive recurrences in young (⩽40 years) women more aggressive than their primary tumours?

por Sigal-Zafrani, B, Bollet, M A, Antoni, G, Savignoni, A, Vincent-Salomon, A, Pierga, J-Y, Salmon, R, Sastre-Garau, X, Fourquet, A
Publicado 2007

Low expression of bcl-2 in Brca1-associated breast cancers

por Freneaux, P, Stoppa-Lyonnet, D, Mouret, E, Kambouchner, M, Nicolas, A, Zafrani, B, Vincent-Salomon, A, Fourquet, A, Magdelenat, H, Sastre-Garau, X
Publicado 2000

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay

por Mouttet, D., Laé, M., Caly, M., Gentien, D., Carpentier, S., Peyro-Saint-Paul, H., Vincent-Salomon, A., Rouzier, R., Sigal-Zafrani, B., Sastre-Garau, X., Reyal, F.
Publicado 2016

High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies

por Bollet, M A, Savignoni, A, Pierga, J-Y, Lae, M, Fourchotte, V, Kirova, Y M, Dendale, R, Campana, F, Sigal-Zafrani, B, Salmon, R, Fourquet, A, Vincent-Salomon, A
Publicado 2008

HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?

por Vincent-Salomon, A, Pierga, J-Y, Couturier, J, d'Enghien, C D, Nos, C, Sigal-Zafrani, B, Lae, M, Fréneaux, P, Diéras, V, Thiéry, J-P, Sastre-Garau, X
Publicado 2007

Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma

por Daveau, C, Baulies, S, Lalloum, M, Bollet, M, Sigal-Zafrani, B, Sastre, X, Vincent-Salomon, A, Tardivon, A, Thibault, F, Pierga, J Y, Cottu, P, Sablin, M P, Rouzier, R, Malhaire, C, Mallon, P, Reyal, F
Publicado 2014

Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation

por de Plater, L, Laugé, A, Guyader, C, Poupon, M-F, Assayag, F, de Cremoux, P, Vincent-Salomon, A, Stoppa-Lyonnet, D, Sigal-Zafrani, B, Fontaine, J-J, Brough, R, Lord, C J, Ashworth, A, Cottu, P, Decaudin, D, Marangoni, E
Publicado 2010

Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001)

por Mauriac, L, Luporsi, E, Cutuli, B, Fourquet, A, Garbay, J R, Giard, S, Spyratos, F, Sigal-Zafrani, B, Dilhuydy, J M, Acharian, V, Balu-Maestro, C, Blanc-Vincent, M P, Cohen-Solal, C, De Lafontan, B, Dilhuydy, M H, Duquesne, B, Gilles, R, Lesur, A, Shen, N, Cany, L, Dagousset, I, Gaspard, M H, Hoarau, H, Hubert, A, Monira, M H, Perrié, N, Romieu, G
Publicado 2003